6-MAPB
6-MAPB (6-Methylaminopropylbenzofuran) is a synthetic entactogen and stimulant of the benzofuran class. It is structurally related to MDMA and 6-APB, and it is known for its psychoactive effects.
Chemical Structure and Properties[edit]
6-MAPB is a benzofuran derivative, which means it contains a benzene ring fused to a furan ring. The chemical structure of 6-MAPB is similar to that of MDMA (3,4-methylenedioxy-N-methylamphetamine), but with a benzofuran ring replacing the methylenedioxy ring. The molecular formula of 6-MAPB is C12H15NO, and its molecular weight is 189.25 g/mol.
Pharmacology[edit]
6-MAPB acts primarily as a releasing agent of serotonin, dopamine, and norepinephrine. This action is similar to that of MDMA, which is known for its ability to induce feelings of euphoria, increased sociability, and empathy. The exact mechanism of action of 6-MAPB is not fully understood, but it is believed to increase the levels of these neurotransmitters in the brain by inhibiting their reuptake and promoting their release.
Effects[edit]
The effects of 6-MAPB are reported to be similar to those of MDMA and 6-APB. Users have described feelings of euphoria, increased energy, enhanced sensory perception, and emotional closeness. The onset of effects typically occurs within 30 to 60 minutes after ingestion, with the peak effects lasting for 3 to 4 hours. The total duration of effects can last up to 6 to 8 hours.
Legal Status[edit]
The legal status of 6-MAPB varies by country. In some jurisdictions, it is classified as a controlled substance, while in others, it may be legal or unregulated. It is important to check the specific laws in your country or region regarding the possession, use, and distribution of 6-MAPB.
Safety and Risks[edit]
As with other psychoactive substances, the use of 6-MAPB carries potential risks. These can include adverse physical and psychological effects, such as increased heart rate, hypertension, anxiety, and paranoia. There is also the potential for neurotoxicity and other long-term health effects, although the extent of these risks is not well-documented due to the limited research on 6-MAPB.
Related Compounds[edit]
See Also[edit]
References[edit]
External Links[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa
Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends ✔ Tele visits available with certain limitations Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
